Ketryx
- 06/12/2023
- Series A
- $14,000,000
Ketryx takes a risk-based approach to medical device development. Our end-to-end platform simplifies FDA compliance and safety for regulated medical software development. Use built-in industry standards and familiar development tools like Jira to create safe software, collect evidence, verify, and validate.
- Industry Software Development
- Website https://www.ketryx.com/
- LinkedIn https://www.linkedin.com/company/ketryx/about/
Related People
Erez KaminskiFounder
Erez Kaminski is the CEO and Founder of Ketryx Corporation, a company striving to create innovative new approaches to regulated software development. Over the last decade, he worked in various industries, including computational mathematics, biotech, and energy, developing mission-critical applications like monitoring systems for pharmaceutical equipment and AI for medication management. Erez is deeply concerned with improving patient care and health outcomes with software solutions. Through Ketryx, he is redefining the complex process of regulated software development and empowering others to change lives and improve software safety and quality.
Prior to Ketryx, Erez worked with Amgen, the world’s largest biotechnology company, as the head of AI/ML for their medical device division and with Wolfram Research, the builders of Mathematica and Wolfram|Alpha. Throughout his career Erez has helped companies large and small build and improve the safety and reliability of their software. He now dedicates his time and focus to improving patient safety and expanding the possibilities for regulated software development, especially as they pertain to AI/ML and Open Source software.